Trial Profile
An Open Label Study to Evaluate the Tolerability and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in Combination With Cyclosporine Microemulsion (CsA-ME) in Maintenance Renal Transplant Recipients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 04 Nov 2011
Price :
$35
*
At a glance
- Drugs Mycophenolate sodium (Primary) ; Ciclosporin; Corticosteroids
- Indications Renal transplant rejection
- Focus Adverse reactions; Therapeutic Use
- Sponsors Novartis
- 04 Nov 2011 New trial record